Dr. Maha Hussain on Novel Approaches in Prostate Cancer

Video

In Partnership With:

Maha Hussain, MD, Professor of Medicine and Urology, University of Michigan, associate director, Clinical Research, co-leader, Prostate Cancer/GU Oncology Program, assistant chief, Clinical Research at the Division of Hematology/ Oncology, University of Michigan Comprehensive Cancer Center, discusses new therapeutic approaches in castration-resistance prostate cancer.

There are several agents currently being tested targeting different aspect of the androgen-receptor in the setting of castration-resistance prostate cancer. Some drugs target the androgen-receptor itself, others target different sources of androgen, and there are also hybrid approaches, said Maha.

Whether or not it is better to have a multi-targeted approach remains unknown, said Maha.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD